Back to Journals » Nanotechnology, Science and Applications » Volume 1

Vibrio fischeri and Escherichia coli adhesion tendencies towards photolithographically modified nanosmooth poly (tert-butyl methacrylate) polymer surfaces

Authors Ivanova E, Mitik-Dineva N, Mocanasu R, Murphy S, Wang J, van Riessen G, Crawford R

Published 19 September 2008 Volume 2008:1 Pages 33—44


Review by Single-blind

Peer reviewer comments 3

Elena P Ivanova1, Natasa Mitik-Dineva1, Radu C Mocanasu1, Sarah Murphy1, James Wang2, Grant van Riessen3, Russell J Crawford1

1Faculty Life and Social Sciences; 2IRIS, Swinburne University of Technology, Hawthorn, Victoria, Australia; 3Centre for Materials and Surface Science, La Trobe University, Melbourne, Victoria, Australia

Abstract: This study reports the adhesion behavior of two bacterial species, Vibrio fischeri and Escherichia coli, to the photoresistant poly(tert-butyl methacrylate) (P(tBMA)) polymer surface. The data has demonstrated that ultraviolet irradiation of P(tBMA) was able to provide control over bacterial adhesion tendencies. Following photolithography, several of the surface characteristics of P(tBMA) were found to be altered. Atomic force microscopy analysis indicated that photolithographically modified P(tBMA) (henceforth termed ‘modified polymer’) appeared as a ‘nanosmooth’ surface with an average surface roughness of 1.6 nm. Although confocal laser scanning microscopy and scanning electron microscopy analysis clearly demonstrated that V. fischeri and E. coli presented largely different patterns of attachment in order to adhere to the same surfaces, both species exhibited a greater adhesion propensity towards the ‘nanosmooth’ surface. The adhesion of both species to the modified polymer surface appeared to be facilitated by an elevated production of extracellular polymeric substances when in contact with the substrate.

Keywords: poly(tert-butylmethacrylate) polymeric surfaces, surface nanotopography, bacterial attachment, extracellular polymeric substances

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

High doses of vitamin A impair iron absorption

Gabriel FR, Suen VM, Marchini JS, Dutra de Oliveira JE

Nutrition and Dietary Supplements 2012, 4:61-65

Published Date: 1 October 2012

Drug-resistant tuberculosis: emerging treatment options

Adhvaryu MR, Vakharia BC

Clinical Pharmacology: Advances and Applications 2011, 3:51-67

Published Date: 14 December 2011

Recommendation for optimal management of severe refractory asthma

Jaymin B Morjaria, Riccardo Polosa

Journal of Asthma and Allergy 2010, 3:43-56

Published Date: 26 July 2010

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer

Mohamedtaki A Tejani, Roger B Cohen, Ranee Mehra

Biologics: Targets and Therapy 2010, 4:173-185

Published Date: 28 June 2010

Gout disease-specific quality of life and the association with gout characteristics

Jan D Hirsch, Robert Terkeltaub, Dinesh Khanna, et al

Patient Related Outcome Measures 2010, 1:1-8

Published Date: 31 March 2010

Trabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma

Katherine A Thornton

Core Evidence 2009, 4:191-198

Published Date: 21 August 2009

Agomelatine: The evidence for its place in the treatment of depression

Daniela Eser, Thomas C Baghai, Hans-Jürgen Möller

Core Evidence 2009, 4:171-179

Published Date: 5 August 2009